Instituto Nacional de Investigação Agrária e Veterinária, I.P. (INIAV, I.P.), Oeiras, Portugal.
Centro de Investigação Interdisciplinar em Sanidade Animal (CIISA), Faculdade de Medicina Veterinária, Universidade de Lisboa, Avenida da Universidade Técnica, Lisboa, Portugal.
Transbound Emerg Dis. 2022 Nov;69(6):3637-3650. doi: 10.1111/tbed.14734. Epub 2022 Oct 26.
The 2018 outbreak of myxomatosis in the Iberian hare (Lepus granatensis) has been hypothesized to originate from a species jump of the rabbit-associated myxoma virus (MYXV), after natural recombination with an unknown poxvirus. Iberian hares were long considered resistant to myxomatosis as no prior outbreaks were reported. To provide insights into the emergence of this recombinant virus (ha-MYXV), we investigated serum samples from 451 Iberian hares collected over two time periods almost two decades apart, 1994-1999 and 2017-2019 for the presence of antibodies and MYXV-DNA. First, we screened all serum samples using a rabbit commercial indirect ELISA (iELISA) and then tested a subset of these samples in parallel using indirect immunofluorescence test (IFT), competitive ELISA (cELISA) and qPCR targeting M000.5L/R gene conserved in MYXV and ha-MYXV. The cut-off of iELISA relative index 10 = 6.1 was selected from a semiparametric finite mixture analysis aiming to minimize the probability of false positive results. Overall, MYXV related-antibodies were detected in 57 hares (12.6%) including 38 apparently healthy hares (n = 10, sampled in 1994-1999, none MYXV-DNA positive, and n = 28 sampled in 2017-2019 of which four were also ha-MYXV-DNA positive) and 19 found-dead and ha-MYXV-DNA-positive sampled in 2018-2019. Interestingly, four seronegative hares sampled in 1997 were MYXV-DNA positive by qPCR, the result being confirmed by sequencing of three of them. For the Iberian hares hunted or live trapped (both apparently health), seroprevalence was significantly higher in 2017-2019 (13.0%, CI95% 9.2-18.2%) than in 1994-1999 (5.4%, CI95% 3.0-9.6%) (p = .009). Within the second period, seroprevalence was significantly higher in 2019 compared to 2017 (24.7 vs 1.7% considering all the sample, p = .007), and lower during the winter than the autumn (p < .001). While our molecular and serological results show that Iberian hares have been in contact with MYXV or an antigenically similar virus at least since 1996, they also show an increase in seroprevalence in 2018-2019. The remote contact with MYXV may have occurred with strains that circulated in rabbits, or with unnoticed strains already circulating in Iberian hare populations. This work strongly suggests the infection of Iberian hares with MYXV or an antigenically related virus, at least 20 years before the severe virus outbreaks were registered in 2018.
2018 年,在伊比利亚兔(Lepus granatensis)中爆发的黏液瘤病被假设起源于兔相关黏液瘤病毒(MYXV)的物种跳跃,之后与一种未知的痘病毒发生了自然重组。伊比利亚兔长期以来被认为对黏液瘤病具有抗性,因为以前没有报告过此类疾病的爆发。为了深入了解这种重组病毒(ha-MYXV)的出现,我们调查了在将近 20 年的两个时间间隔内采集的 451 只伊比利亚兔的血清样本,即 1994-1999 年和 2017-2019 年,以检测存在抗体和 MYXV-DNA。首先,我们使用兔科的商业间接 ELISA(iELISA)对所有血清样本进行了筛选,然后使用间接免疫荧光试验(IFT)、竞争 ELISA(cELISA)和 qPCR 对其中一部分样本进行了平行检测,qPCR 针对的是 MYXV 和 ha-MYXV 中保守的 M000.5L/R 基因。选择 iELISA 相对指数 10 = 6.1 作为截断值,这是通过半参数有限混合分析得出的,旨在最大限度地降低假阳性结果的概率。总的来说,在 57 只兔子(12.6%)中检测到了与 MYXV 相关的抗体,其中包括 38 只显然健康的兔子(n = 10,1994-1999 年采样,均未检测到 MYXV-DNA,28 只 2017-2019 年采样,其中 4 只也检测到了 ha-MYXV-DNA)和 19 只在 2018-2019 年发现死亡并携带 ha-MYXV-DNA 的兔子。有趣的是,在 1997 年采样的 4 只血清阴性兔子的 qPCR 结果为 MYXV-DNA 阳性,其中 3 只的测序结果证实了这一结果。对于被猎捕或活捕的伊比利亚兔(均为显然健康),2017-2019 年的血清阳性率(13.0%,95%CI 9.2-18.2%)明显高于 1994-1999 年(5.4%,95%CI 3.0-9.6%)(p = 0.009)。在第二个时期,与 2017 年相比,2019 年的血清阳性率显著更高(考虑所有样本时,24.7%比 1.7%,p = 0.007),而在冬季的血清阳性率则低于秋季(p < 0.001)。尽管我们的分子和血清学结果表明,伊比利亚兔自 1996 年以来至少与 MYXV 或具有类似抗原性的病毒有过接触,但它们也显示出 2018-2019 年血清阳性率的增加。与 MYXV 的远程接触可能发生在在兔科中传播的菌株中,也可能发生在已经在伊比利亚兔种群中传播的未被注意到的菌株中。这项工作强烈表明,伊比利亚兔至少在 2018 年发生严重病毒爆发之前的 20 年前就已经感染了 MYXV 或具有类似抗原性的病毒。